Featured Papers
Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study Roberto Perez, Andrew V. Schally*, Petra Popovics, Renzhi Cai, Wei Sha, Ricardo Rincon, and Ferenc G. Rick |
|
Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature Kristy J. Gotink, Henk J. Broxterman, Richard J. Honeywell, Henk Dekker, Richard R. de Haas, Kiersten M. Miles, Remi Adelaiye, Arjan W. Griffioen, Godefridus J. Peters, Roberto Pili, and Henk M.W. Verheul Abstract | PDF | Supplementary Materials p844 -853 |
|